Articles in Scholarly Journals [Incomplete List]

1. Stem cell properties and the side population cells as a target for interferon-a in adult T-cell leukemia/lymphoma
   Biochemical and Biophysical Research Communications, 2007
2. Caveolin-1 Triggers T-cell Activation via CD26 in Association with CARMA1
   Journal of Biological Chemistry, vol. 282, no. 13, pp. 10117–10131, 2007
3. Transcriptional Up-regulation of Inhibitory PAS Domain Protein Gene Expression by Hypoxia-inducible Factor 1 (HIF-1): A NEGATIVE FEEDBACK REGULATORY CIRCUIT IN HIF-1-MEDIATED SIGNALING IN HYPOXIC CELLS
   Journal of Biological Chemistry, vol. 282, no. 19, pp. 14073–14082, 2007
4. Knockdown of XAB2 Enhances All-Trans Retinoic Acid-Induced Cellular Differentiation in All-Trans Retinoic Acid-Sensitive and -Resistant Cancer Cells
   Cancer Research, vol. 67, no. 3, pp. 1019–1029, 2007
5. Humanized Anti-CD26 Monoclonal Antibody as a Treatment for Malignant Mesothelioma Tumors
   Clinical Cancer Research, vol. 13, no. 14, pp. 4191–4200, 2007
6. Could Serum Antibody to Poly(ADP-Ribose) and/or Histone H1 Be Marker for Senile Dementia of Alzheimer Type?
   Annals of the New York Academy of Sciences, vol. 1109, no. 1, pp. 338–344, 2007
7. CD26/Dipeptidyl Peptidase IV as a Novel Therapeutic Target for Cancer and Immune Disorders
   Mini Reviews in Medicinal Chemistry, vol. 7, no. 3, pp. 253–273, 2007
8. Anti-CD26 Monoclonal Antibody-Mediated G1-S Arrest of Human Renal Clear Cell Carcinoma Caki-2 Is Associated with Retinoblastoma Substrate Dephosphorylation, Cyclin-Dependent Kinase 2 Reduction, p27kip1 Enhancement, and Disruption of Binding to the Extracellular Matrix
   Clinical Cancer Research, vol. 12, no. 11, pp. 3470–3477, 2006
9. Recurrence of ovarian endometrioma after laparoscopic excision
   Human Reproduction, vol. 21, no. 8, pp. 2171–2174, 2006
10. Crk-associated substrate lymphocyte type regulates transforming growth factor-ß signaling by inhibiting Smad6 and Smad7
    Oncogene, vol. 26, no. 6, Article ID 1209848, 11 pages, 2006
11. T-cell activation via CD26 and caveolin-1 in rheumatoid synovium
    Modern Rheumatology, vol. 16, no. 1, pp. 3–13, 2006
12. CD26+ T cells in the pathogenesis of asthma
    Clinical and Experimental Immunology, vol. 139, no. 1, pp. 13–16, 2005
13. CD26 Mediates Dissociation of Tollip and IRAK-1 from Caveolin-1 and Induces Upregulation of CD86 on Antigen-Presenting Cells
    Molecular and Cellular Biology, vol. 25, no. 17, pp. 7743–7757, 2005
14. Regulation of p38 Phosphorylation and Topoisomerase II  Expression in the B-Cell Lymphoma Line Jiyoye by CD26/Dipeptidyl Peptidase IV Is Associated with Enhanced In vitro and In vivo Sensitivity to Doxorubicin
    Cancer Research, vol. 65, no. 5, pp. 1973–1983, 2005
15. CD26 Regulates p38 Mitogen-Activated Protein Kinase-Dependent Phosphorylation of Integrin  1, Adhesion to Extracellular Matrix, and Tumorigenicity of T-Anaplastic Large Cell Lymphoma Karpas 299
    Cancer Research, vol. 65, no. 15, pp. 6950–6956, 2005
16. Nedd9 Protein, a Cas-L Homologue, Is Upregulated After Transient Global Ischemia in Rats: Possible Involvement of Nedd9 in the Differentiation of Neurons After Ischemia
    Stroke, vol. 36, no. 11, pp. 2457–2462, 2005
17. The Distinct Agonistic Properties of the Phenylpyrazolosteroid Cortivazol Reveal Interdomain Communication within the Glucocorticoid Receptor
    Molecular Endocrinology, vol. 19, no. 5, pp. 1110–1124, 2005
18. HEXIM1 forms a transcriptionally abortive complex with glucocorticoid receptor without involving 7SK RNA and positive transcription elongation factor b
    Proceedings of the National Academy of Sciences, vol. 102, no. 24, pp. 8555–8560, 2005
19. CD26 up-regulates expression of CD86 on antigen-presenting cells by means of caveolin-1
    Proceedings of the National Academy of Sciences, vol. 101, no. 39, pp. 14186–14191, 2004
20. The tetraspanin CD9 is preferentially expressed on the human CD4+CD45RA+ naive T cell population and is involved in T cell activation
    Clinical and Experimental Immunology, vol. 137, no. 1, pp. 101–108, 2004
21. Selective modulation of glucocorticoid receptor function toward development of novel antiinflammation: lessons from a phenylpyrazolosteroid cortivazol
    Modern Rheumatology, vol. 14, no. 5, pp. 347–355, 2004
22. HTLV-I Tax induces and associates with Crk-associated substrate lymphocyte type (Cas-L)
    Oncogene, vol. 24, no. 7, Article ID 1208261, 9 pages, 2004
23. A novel mechanism for imatinib mesylate (STI571) resistance in CML cell line KT-1: role of TC-PTP in modulating signals downstream from the BCR-ABL fusion protein
    Experimental Hematology, vol. 32, no. 11, pp. 1057–1063, 2004
24. Effect of CD26/dipeptidyl peptidase IV on Jurkat sensitivity to G2/M arrest induced by topoisomerase II inhibitors
    British Journal of Cancer, vol. 88, no. 3, Article ID 6600791, 7 pages, 2003
25. CD26/dipeptidyl peptidase IV enhances expression of topoisomerase II alpha and sensitivity to apoptosis induced by topoisomerase II inhibitors
    British Journal of Cancer, vol. 89, no. 7, Article ID 6601253, 8 pages, 2003
26. CD26: a key molecule in immune regulation and autoimmune diseases
    Modern Rheumatology, vol. 13, no. 3, pp. 199–204, 2003
27. Role of Crk-associated substrate lymphocyte type in the pathophysiology of rheumatoid arthritis intax transgenic mice and in humans
    Arthritis & Rheumatism, vol. 48, no. 7, pp. 1890–1900, 2003
28. Association of CD26 with CD45RA outside lipid rafts attenuates cord blood T-cell activation
    Blood, vol. 103, no. 3, pp. 1002–1010, 2003
29. T-large granular lymphocyte lymphoproliferative disorder: expression of CD26 as a marker of clinically aggressive disease and characterization of marrow inhibition
    British Journal of Haematology, vol. 121, no. 6, pp. 857–865, 2003
30. Ebastine inhibits T cell migration, production of Th2-type cytokines and proinflammatory cytokines
    Clinical Experimental Allergy, vol. 33, no. 11, pp. 1544–1554, 2003
31. Suppression of NF-kappaB-dependent gene expression by a hexamethylene bisacetamide-inducible protein HEXIM1 in human vascular smooth muscle cells
    Genes to Cells, vol. 8, no. 2, pp. 95–107, 2003
32. Role of the Glucocorticoid Receptor for Regulation of Hypoxia-dependent Gene Expression
    Journal of Biological Chemistry, vol. 278, no. 35, pp. 33384–33391, 2003
33. Distinct Interaction of Cortivazol with the Ligand Binding Domain Confers Glucocorticoid Receptor Specificity. CORTIVAZOL IS A SPECIFIC LIGAND FOR THE GLUCOCORTICOID RECEPTOR
    Journal of Biological Chemistry, vol. 277, no. 7, pp. 5529–5540, 2002
34. Cytokine Receptor Common beta Subunit-mediated STAT5 Activation Confers NF-kappa B Activation in Murine proB Cell Line Ba/F3 Cells
    Journal of Biological Chemistry, vol. 277, no. 8, pp. 6254–6265, 2002
35. CD27 and CD40 Inhibit p53-independent Mitochondrial Pathways in Apoptosis of B Cells Induced by B Cell Receptor Ligation
    Journal of Biological Chemistry, vol. 277, no. 49, pp. 46950–46958, 2002
36. G1/S cell cycle arrest provoked in human T cells by antibody to CD26
    Immunology, vol. 107, no. 3, pp. 325–333, 2002
37. Distinctive signaling pathways through CD82 and ß1 integrins in human T cells
    European Journal of Immunology, vol. 32, no. 5, p. 1328, 2002
38. Regulation of epithelial and lymphocyte cell adhesion by adenosine deaminase?CD26 interaction
    Biochemical Journal, vol. 361, no. 2, p. 203, 2002
39. Human GM-CSF induces HIV-1 LTR by multiple signalling pathways
    Biochimie, vol. 84, no. 7, pp. 633–642, 2002
40. Soluble CD26/dipeptidyl peptidase IV enhances transendothelial migration via its interaction with mannose 6-phosphate/insulin-like growth factor II receptor
    Cellular Immunology, vol. 215, no. 1, pp. 106–110, 2002
41. Intestinal epithelial cells express and secrete the CD43 glycoform that contains core 2 O-glycans
    Microbes and Infection, vol. 3, no. 9, pp. 723–728, 2001
42. Recognition of cell surface GD3 by monoclonal antibody anti-6C2 in rheumatoid arthritis synovial fluid: Expression on human T cells with transendothelial migratory activity
    Arthritis & Rheumatism, vol. 44, no. 2, pp. 296–306, 2001
43. CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO
    Proceedings of the National Academy of Sciences, vol. 98, no. 21, pp. 12138–12143, 2001
44. Comodulation of CXCR4 and CD26 in Human Lymphocytes
    Journal of Biological Chemistry, vol. 276, no. 22, pp. 19532–19539, 2001
45. Functional Modulation of the Glucocorticoid Receptor and Suppression of NF-kappa B-dependent Transcription by Ursodeoxycholic Acid
    Journal of Biological Chemistry, vol. 276, no. 50, pp. 47371–47378, 2001
46. Signaling events following chemokine receptor ligation in human dendritic cells at different developmental stages
    International Immunology, vol. 13, no. 2, pp. 167–179, 2001
47. B cell co-receptors regulating T cell-dependent antibody production in common variable immunodeficiency: CD27 pathway defects identify subsets of severely immuno-compromised patients
    International Immunology, vol. 13, no. 7, pp. 871–876, 2001
48. Internalization of CD26 by mannose 6-phosphate/insulin-like growth factor II receptor contributes to T cell activation
    Proceedings of the National Academy of Sciences, vol. 97, no. 15, pp. 8439–8444, 2000
49. Novel in vitro effects of bucillamine: Inhibitory effects on proinflammatory cytokine production and transendothelial migration of T cells
    Arthritis & Rheumatism, vol. 43, no. 7, pp. 1616–1623, 2000
50. Activation of mitogen-activated protein kinase through a5/ß1 integrin is required for cell cycle progression of B progenitor cell line, Reh, on human marrow stromal cells
    Experimental Hematology, vol. 28, no. 10, pp. 1147–1157, 2000
51. Good or evil: CD26 and HIV infection
    Journal of Dermatological Science, vol. 22, no. 3, pp. 152–160, 2000
52. Beta 1-integrin-mediated cell signaling in T lymphocytes
    Journal of Dermatological Science, vol. 23, no. 2, pp. 75–86, 2000
53. Human T lymphocyte populations which bind to P- or E-selectin are enriched with cells expressing core 2 O-glycans
    Immunology Letters, vol. 67, no. 2, pp. 117–124, 1999
54. Decreased Dipeptidyl Peptidase IV Enzyme Activity of Plasma Soluble CD26 and Its Inverse Correlation with HIV-1 RNA in HIV-1 Infected Individuals
    Clinical Immunology, vol. 91, no. 3, pp. 283–295, 1999
55. Specific inhibition of TH2-type cytokine production from human peripheral T cells by terfenadine in vitro
    Clinical Experimental Allergy, vol. 29, no. 9, pp. 1281–1286, 1999
56. CD26/Dipeptidyl Peptidase IV in Context: the Different Roles of a Multifunctional Ectoenzyme in Malignant Transformation
    Journal of Experimental Medicine, vol. 190, no. 3, pp. 301–306, 1999
57. Core 2-containing O-glycans on CD43 are preferentially expressed in the memory subset of human CD4 T cells
    International Immunology, vol. 11, no. 2, pp. 259–268, 1999
58. CD26/dipeptidyl peptidase IV differentially regulates the chemotaxis of T cells and monocytes toward RANTES: possible mechanism for the switch from innate to acquired immune response
    International Immunology, vol. 11, no. 3, pp. 417–426, 1999
59. The structure and function of CD26 in the T-cell immune response
    Immunological Reviews, vol. 161, no. 1, pp. 55–70, 1998
60. Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha ) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage
    Proceedings of the National Academy of Sciences, vol. 95, no. 11, pp. 6331–6336, 1998
61. T Cell Receptor-mediated Tyrosine Phosphorylation of Cas-L, a 105-kDa Crk-associated Substrate-related Protein, and Its Association of Crk and C3G
    Journal of Biological Chemistry, vol. 273, no. 11, pp. 6446–6451, 1998
62. CD27, a Member of the Tumor Necrosis Factor Receptor Superfamily, Activates NF-kappa B and Stress-activated Protein Kinase/c-Jun N-terminal Kinase via TRAF2, TRAF5, and NF-kappa B-inducing Kinase
    Journal of Biological Chemistry, vol. 273, no. 21, pp. 13353–13358, 1998
63. Interaction of Hic-5, A Senescence-related Protein, with Focal Adhesion Kinase
    Journal of Biological Chemistry, vol. 273, no. 41, pp. 26516–26521, 1998
64. Interleukin-12 Induces Tyrosine Phosphorylation of an 85-kDa Protein Associated with the Interleukin-12 Receptor ß1 Subunit
    Cellular Immunology, vol. 186, no. 1, pp. 39–44, 1998
65. Negative regulation of the anti-human immunodeficiency virus and chemotactic activity of human stromal cell-derived factor 1a by CD26/dipeptidyl peptidase IV
    FEBS Letters, vol. 431, no. 2, pp. 236–240, 1998
66. Correlation of the epitopes defined by anti-CD26 mAbs and CD26 function
    Molecular Immunology, vol. 35, no. 1, pp. 13–21, 1998
67. Surrogate thrombopoietin
    Immunology Letters, vol. 61, no. 2-3, pp. 73–78, 1998
68. Journal of Clinical Immunology, vol. 17, no. 3, pp. 247–252, 1997
69. Journal of Clinical Immunology, vol. 17, no. 1, pp. 53–62, 1997
70. CD27/CD70 Interaction Contributes to the Activation and the Function of Human Autoreactive CD27+Regulatory T Cells, ,
    Cellular Immunology, vol. 179, no. 1, pp. 48–54, 1997
71. B cell subpopulations separated by CD27 and crucial collaboration of CD27+ B cells and helper T cells in immunoglobulin production
    European Journal of Immunology, vol. 27, no. 8, pp. 2073–2079, 1997
72. Ligation of the T cell antigen receptor induces tyrosine phosphorylation of p105CasL, a member of the p130Cas-related docking protein family, and its subsequent binding to the Src homology 2 domain of c-Crk
    European Journal of Immunology, vol. 27, no. 8, pp. 2113–2117, 1997
73. Tyrosine Phosphorylation of Crk-associated Substrates by Focal Adhesion Kinase. A PUTATIVE MECHANISM FOR THE INTEGRIN-MEDIATED TYROSINE PHOSPHORYLATION OF Crk-ASSOCIATED SUBSTRATES
    Journal of Biological Chemistry, vol. 272, no. 46, pp. 29083–29090, 1997
74. Aids, vol. 11, no. 14, pp. 1719–1724, 1997
75. Structure and function of Cas-L, a 105-kD Crk-associated substrate- related protein that is involved in beta 1 integrin-mediated signaling in lymphocytes
    Journal of Experimental Medicine, vol. 184, no. 4, pp. 1365–1375, 1996
76. Src Kinase Plays an Essential Role in Integrin-Mediated Tyrosine Phosphorylation of Crk-Associated Substrate p130Cas
    Biochemical and Biophysical Research Communications, vol. 222, no. 2, pp. 338–343, 1996
77. Influence of CD26 and integrins on the antigen sensitivity of human memory T cells
    Human Immunology, vol. 50, no. 2, pp. 79–90, 1996
78. Focal Adhesion Kinase (pp125FAK) Is Tyrosine Phosphorylated after Engagement of a4ß1 and a5ß1 Integrins on Human T-Lymphoblastic Cells
    Cellular Immunology, vol. 161, no. 1, pp. 8–13, 1995
79. Comparison of lymphokine secretion and mRNA expression in the CD45RA+ and CD45RO+ subsets of human peripheral blood CD4+ and CD8+ lymphocytes
    European Journal of Immunology, vol. 25, no. 3, pp. 644–648, 1995
80. CD27/CD70 interaction directly drives B cell IgG and IgM synthesis
    European Journal of Immunology, vol. 25, no. 10, pp. 2825–2829, 1995
81. A Novel Form of Dipeptidylpeptidase IV Found in Human Serum
    Journal of Biological Chemistry, vol. 270, no. 23, pp. 14107–14114, 1995
82. Integrin-mediated Cell Adhesion Promotes Tyrosine Phosphorylation of p130[IMAGE], a Src Homology 3-containing Molecule Having Multiple Src Homology 2-binding Motifs
    Journal of Biological Chemistry, vol. 270, no. 25, pp. 15398–15402, 1995
83. CD27-CD70 Interactions Regulate B-Cell Activation by T Cells
    Proceedings of the National Academy of Sciences, vol. 92, no. 24, pp. 11249–11253, 1995
84. Role of CD26/Dipeptidyl Peptidase IV in Human Immunodeficiency Virus Type 1 Infection and Apoptosis
    Proceedings of the National Academy of Sciences, vol. 91, no. 21, pp. 9960–9964, 1994
85. Enhancement of Antigen-Induced T-Cell Proliferation by Soluble CD26/ Dipeptidyl Peptidase IV
    Proceedings of the National Academy of Sciences, vol. 91, no. 8, pp. 3082–3086, 1994
86. CD Antigens 1993
    Leukemia and Lymphoma, vol. 13, pp. 59–60, 1994
87. Differential Regulation of CD27 Expression on Subsets of CD4 T Cells
    Cellular Immunology, vol. 158, no. 2, pp. 365–375, 1994
88. CD antigens 1993
    Immunology Today, vol. 15, no. 3, pp. 98–99, 1994
89. The 4F9 Antigen Is a Member of the Tetra Spans Transmembrane Protein Family and Functions as an Accessory Molecule in T Cell Activation and Adhesion
    Cellular Immunology, vol. 152, no. 1, pp. 249–260, 1993
90. Direct Demonstration of the CD27 Molecule Involved in the Negative Regulatory Effect on T Cell Activation
    Cellular Immunology, vol. 152, no. 1, pp. 279–285, 1993
91. The Costimulatory Activity of the CD26 Antigen Requires Dipeptidyl Peptidase IV Enzymatic Activity
    Proceedings of the National Academy of Sciences, vol. 90, no. 10, pp. 4586–4590, 1993
92. Ligation of VLA-4 on T cells stimulates tyrosine phosphorylation of a 105-kD protein
    Journal of Experimental Medicine, vol. 175, no. 4, pp. 1045–1053, 1992
93. The cellular basis for lack of antibody response to hepatitis B vaccine in humans
    Journal of Experimental Medicine, vol. 173, no. 3, pp. 531–538, 1991
94. VLA-4 mediates CD3-dependent CD4+ T cell activation via the CS1 alternatively spliced domain of fibronectin
    Journal of Experimental Medicine, vol. 172, no. 4, pp. 1185–1192, 1990
95. A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes
    Journal of Experimental Medicine, vol. 169, no. 4, pp. 1421–1434, 1989
96. Activation of CD4 cells by fibronectin and anti-CD3 antibody. A synergistic effect mediated by the VLA-5 fibronectin receptor complex
    Journal of Experimental Medicine, vol. 170, no. 4, pp. 1133–1148, 1989
97. Molecular Interactions, T-Cell Subsets and a Role of the CD4/CD8:p56lck Complex in Human T-Cell Activation
    Immunological Reviews, vol. 111, no. 1, pp. 225–266, 1989
98. Decrease of suppressor inducer (cd4+ 2h4+) t cells in multiple sclerosis cerebrospinal fluid
    Annals of Neurology, vol. 25, no. 5, pp. 494–499, 1989
99. Antilymphocyte antibodies against CD4+2H4+ cell populations in patients with systemic lupus erythematosus
    Arthritis & Rheumatism, vol. 32, no. 4, pp. 398–405, 1989
100. Functional characterization of the CD45R (2H4) molecule on CD8 (T8) cells in the autologous mixed lymphocyte reaction system
     European Journal of Immunology, vol. 19, no. 4, pp. 747–755, 1989
101. Amplification of suppressor inducer pathway with monoclonal antibody, anti-2H4, identifying a novel epitope of the common leukocyte antigen/T200 antigen
     Cellular Immunology, vol. 118, no. 1, pp. 68–84, 1989
102. Generation of CD8 (T8) cytotoxic cells has a preferential requirement for CD4+2H4? inducer cells*1
     Cellular Immunology, vol. 111, no. 2, pp. 379–389, 1988
103. CD11 molecule defines two types of suppressor cells within the T8+ population*1
     Cellular Immunology, vol. 111, no. 2, pp. 398–409, 1988
104. Crosslinking CD3 with CD2 using Sepharose-immobilized antibodies enhances T lymphocyte proliferation
     Cellular Immunology, vol. 115, no. 2, pp. 246–256, 1988
105. Monoclonal antibody 4B4 blocks suppression of the immune response to Cryptomeria japonica pollen antigen
     Human Immunology, vol. 22, no. 1, pp. 1–7, 1988
106. Regulatory interactions between members of the immunoglobulin superfamily
     Immunology Today, vol. 9, no. 7-8, pp. 199–203, 1988
107. Abnormalities in CD4+ T-lymphocyte subsets in inflammatory rheumatic diseases*1
     The American Journal of Medicine, vol. 84, no. 5, pp. 817–825, 1988
108. Loss of functional suppression is linked to decreases in circulating suppressor inducer (CD4 + 2H4 +) T Cells in multiple sclerosis
     Annals of Neurology, vol. 24, no. 2, pp. 185–191, 1988
109. Dual-label immunocytochemistry of the active multiple sclerosis lesion: Major histocompatibility complex and activation antigens
     Annals of Neurology, vol. 24, no. 4, pp. 523–531, 1988
110. Role of the 2H4 molecule in the activation of suppressor inducer function
     European Journal of Immunology, vol. 18, no. 5, pp. 731–737, 1988
111. CD4CD45R cells are preferentially activated through the CD2 pathway
     European Journal of Immunology, vol. 18, no. 9, pp. 1473–1476, 1988
112. Lymphocyte Activation: Modulatory Effects Mediated by Interactions between Cell Adhesion Molecules
     Annals of the New York Academy of Sciences, vol. 551, no. 1 Membrane in C, pp. 347–353, 1988
113. Immunohistochemical Analysis of Suppressor-Inducer and Helper-Inducer T Cells in Multiple Sclerosis Brain Tissue
     Annals of the New York Academy of Sciences, vol. 540, no. 1 Advances in N, pp. 306–308, 1988
114. Identification of the sequence required for expression of the 2H4 epitope on the human leukocyte common antigens
     Journal of Experimental Medicine, vol. 166, no. 5, pp. 1567–1572, 1987
115. The subdivision of the T4 (CD4) subset on the basis of the differential expression of L-C/T200 antigens
     Journal of Experimental Medicine, vol. 166, no. 6, pp. 1758–1773, 1987
116. Induction of suppression following autologous mixed lymphocyte reaction; role of a novel 2H4 antigen
     European Journal of Immunology, vol. 17, no. 1, pp. 97–103, 1987
117. Antilymphocyte antibodies and systemic lupus erythematosus
     Arthritis & Rheumatism, vol. 30, no. 2, pp. 225–228, 1987
118. The 2H4 molecule but not the T3-receptor complex is involved in suppressor inducer signals in the AMLR system
     Cellular Immunology, vol. 107, no. 1, pp. 107–114, 1987
119. A novel epitope of the LFA-1 antigen which can distinguish killer effector and suppressor cells in human CD8 cells
     Nature, vol. 330, no. 6147, Article ID 330479a0, 3 pages, 1987
120. The cellular basis for the induction of antigen-specific T8 suppressor cells
     European Journal of Immunology, vol. 16, no. 2, pp. 198–204, 1986
121. Definition of the T-lymphocyte inducer of suppression in primates using a monoclonal antibody
     Cellular Immunology, vol. 94, no. 2, pp. 360–368, 1985
122. Cellular interaction between subsets of T8 population for maximal suppression of antigen-specific antibody response
     Cellular Immunology, vol. 88, no. 1, pp. 75–84, 1984
123. Reactivity of inducer cell subsets and T8-cell activation during the human autologous mixed lymphocyte reaction
     Clinical Immunology and Immunopathology, vol. 30, no. 1, pp. 117–128, 1984
124. Hapten-specific carrier-dependent tolerance induction in man in vitro*1
     Cellular Immunology, vol. 82, no. 2, pp. 415–421, 1983
125. Functional Differences of Anti-T-Cell Antibody in Patients with Systemic Lupus Erythematosus and Ulcerative Colitis
     Scandinavian Journal of Immunology, vol. 18, no. 6, pp. 521–530, 1983
126. Direct demonstration of the function of T cell subsets reactive with anti-T cell antibodies from SLE sera
     Rheumatology International, vol. 1, no. 4, pp. 157–163, 1982
127. Comparison in T- and B-cell markers in patients with Sjögren's syndrome and systemic lupus erythematosus
     Clinical Immunology and Immunopathology, vol. 22, no. 2, pp. 270–278, 1982
128. Evidence of Aberration of T-cell Subsets in Aged Individuals
     Scandinavian Journal of Immunology, vol. 13, no. 2, pp. 151–157, 1981
129. Studies of Anti-Lymphocyte Antibody in Patients with Active SLE.
     Scandinavian Journal of Immunology, vol. 11, no. 5, pp. 479–488, 1980
130. Cell-mediated immunity to platelets in SLE patients with thrombocytopenia: Two different types of lymphocyte stimulation
     Clinical Immunology and Immunopathology, vol. 15, no. 1, pp. 1–10, 1980
131. Characteristics of anti-T-cell antibodies in systemic lupus erythematosus: Evidence for selective reactivity with normal suppressor cells defined by monoclonal antibodies
     Clinical Immunology and Immunopathology, vol. 16, no. 4, pp. 474–484, 1980
132. Enhancement of lymphocyte response to PHA by lysosomal enzymes from polymorphonuclear leukocytes of RA joint fluid
     Inflammation, vol. 4, no. 2, pp. 169–180, 1980
133. Regulation of B cell immunoglobulin secretion by functional subsets of T lymphocytes in man
     European Journal of Immunology, vol. 10, no. 7, pp. 570–572, 1980
134. Restoration of T-cell function in aged mice with long-term administration of levamisole
     Clinical Immunology and Immunopathology, vol. 12, no. 3, pp. 316–322, 1979
135. Altered function of suppressor T lymphocytes in patients with active systemic lupus erythematosus—In vitro immune response to autoantigen
     Clinical Immunology and Immunopathology, vol. 13, no. 2, pp. 161–170, 1979
136. Studies of Anti-lymphocyte Antibody of Patients with Active SLE.
     Scandinavian Journal of Immunology, vol. 10, no. 3, pp. 213–221, 1979
137. In Vitro TNP-Specific Antibody Formation by Peripheral Lymphocytes from Patients with Systemic Lupus Erythematosus
     Scandinavian Journal of Immunology, vol. 6, no. 6-7, pp. 575–579, 1977
138. Cell-mediated immune response in idiopathic thrombocytopenic purpura In vitro cellular response to autologous and homologous platelet and platelet membrane by macrophage inhibitory test
     Clinical Immunology and Immunopathology, vol. 8, no. 2, pp. 181–189, 1977